Cosmetic Emulsion Stability: What a Reformulation Can—and Cannot—Prove
In this article
An Italian skincare brand approached Tsilkov Cosmetics with an unstable product and an urgent deadline. The project required our laboratory to revisit the formulation and processing approach quickly, while keeping the distinction between early screening and longer-term product confidence clear.
This is an important distinction in cosmetic emulsion stability. A promising result after a reformulation can justify further evaluation. It cannot, by itself, establish the shelf life of a finished product.
Investigate before changing everything
A useful troubleshooting discussion begins with the problem as observed: what changed, under which conditions and after how long? The team also needs the formula history, processing information and the intended packaging.
Changing several variables at once may produce a better-looking sample without explaining why it improved. Where practical, keep a record of the changes and the purpose of each trial. That makes the results more useful when the formula is prepared again.
Treat formulation and process as connected
In the project described in our original post, the laboratory revisited the emulsifier system, phase balance and processing temperature. These were development decisions for a specific product, not a universal recipe for correcting instability.
The wider lesson is to discuss how the product is made as well as what it contains. A revised laboratory sample still needs to be considered in the context of the intended manufacturing process and pack.
Use accelerated work as screening, not a shelf-life shortcut
Accelerated conditions can help the team identify weaknesses and compare development directions. They do not compress every aspect of months or years of product behaviour into a few hours. The relationship between a screening result and the intended shelf life needs technical justification.
ISO/TR 18811 provides guidance on cosmetic stability testing and places responsibility on the manufacturer to specify and justify the protocol. For a brand, the practical question is which tests support the intended product and packaging, and what conclusions can reasonably be drawn at each stage.
Keep commercial decisions aligned with the evidence
An urgent deadline does not change what a test has demonstrated. Ask the laboratory to explain which concern has been addressed, what remains under evaluation and whether any further development is needed.
Make those distinctions visible in the project schedule. An improved sample, an approved specification and a product ready for release are separate milestones. Treating them as interchangeable can create pressure to make decisions before the necessary evidence is available.
What to bring to a reformulation discussion
Provide representative samples, observations of the issue, the relevant production history and the planned packaging. State the deadline, but also identify what needs to be achieved by it: a development direction, evaluation samples or finished stock.
The aim of troubleshooting is a repeatable solution with an appropriate evidence base. A fast response is valuable when it begins that process clearly, rather than suggesting that a short trial has settled every stability question.
References
Developed from our original LinkedIn post.